Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fisetin in older patients with sepsis (STOP-Sepsis)
NCT05758246Phase 2Recruiting
- Sponsor
- University of Minnesota
- Start
- Aug 2023
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fisetin in sepsis, sponsored by University of Minnesota. Started Aug 2023; status: recruiting.
02
Drugs
fisetin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT05758246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05758246.